Agilent Announces New ProteoAnalyzer System
16 Januar 2024 - 2:00PM
Business Wire
Automated parallel capillary electrophoresis system simplifies
protein analysis
Agilent Technologies Inc. (NYSE: A) today announced the release
of a new automated parallel capillary electrophoresis system for
protein analysis – the Agilent ProteoAnalyzer system – at the 23rd
Annual PepTalk Conference, being held January 16-19 in San Diego.
This new platform simplifies and improves the efficiency of
analyzing complex protein mixtures, a process central to analytical
workflows across the pharma, biotech, food analysis, and academia
sectors.
Capillary electrophoresis (CE) has established itself as an
indispensable tool for protein separation, as it offers rapid,
high-resolution analysis with minimal sample consumption. The
expanding interest of biopharma in monoclonal antibodies and other
protein targets of potential therapeutic interest is driving the
expected growth in demand for CE solutions.
The Agilent ProteoAnalyzer system brings added efficiency,
versatility, and reliability, particularly in protein QC workflows.
Automating the separation, data processing, and simplifying sample
preparation steps streamlines the analysis workflow, which improves
efficiency and reduces training and related labor costs. The system
also can analyze a wide range of sample types, from crude lysates
to purified fractions. It can analyze different sizes and types of
proteins in a single run and consistently deliver accurate results,
reducing the need for time-consuming and costly reanalysis.
“The Agilent ProteoAnalyzer system introduces a new level of
efficiency, versatility, and reliability to protein analysis,”
commented Knut Wintergerst, vice president and general manager of
the Biomolecular Analysis Division at Agilent. “Automated parallel
capillary electrophoresis simplifies the analysis of complex
mixtures, benefiting diverse sectors from pharma to academia.
Precision and reliability converge, reducing labor costs and
enhancing analytical workflows.”
Kyle Luttgeharm, product manager in Agilent’s Integrated
Genomics Division will present a seminar at PepTalk on Thursday,
January 18 at 12:25 p.m., titled Discover the ProteoAnalyzer
System: Automated Protein Analysis Parallel to None.
Agilent, one of the market leaders in CE, offers automated
electrophoresis systems that see wide use for nucleic acids
analysis, such as NGS QC and IVT RNA applications. Agilent expects
the ProteoAnalyzer to strengthen its position as a key provider of
quality control analysis solutions by extending its CE portfolio
across relevant biomolecule classes.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insights and innovation that help our customers bring
great science to life. Agilent’s full range of solutions includes
instruments, software, services, and expertise that provide trusted
answers to our customers' most challenging questions. The company
generated revenue of $6.83 billion in fiscal 2023 and employs
approximately 18,000 people worldwide. Information about Agilent is
available at www.agilent.com. To receive the latest Agilent news,
please subscribe to the Agilent Newsroom. Follow Agilent on
LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240116745823/en/
Catherine Kaye Agilent Technologies +44 (0)7775 410632
catherine.kaye@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
Von Mai 2023 bis Mai 2024